Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection [Phase 4]
Phase 4 trial update comparing high-dose dual therapy to bismuth-containing quadruple therapy for rescue treatment of Helicobacter pylori in…
-
FDA approval · 2020-04-20FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for esomeprazole magnesium (Ascend Laboratories) to bring a generic product to market.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication [Phase 3]
Phase 3 trial comparing 7-day PPI-based standard triple therapy to 10-day bismuth quadruple therapy for Helicobacter pylori eradication has …
-
FDA approval · 2020-04-01FDA Approved: ESOMEPRAZOLE SODIUM — Original Application (Gland Pharma Limited)
FDA approved the original application for esomeprazole sodium (generic) from Gland Pharma Limited, enabling its marketing in the United Stat…
-
FDA approval · 2020-03-25FDA Approved: OMEPRAZOLE — Original Application (CHAIN DRUG MARKETING ASSOCIATION, INC.)
The FDA approves an original application for omeprazole (generic) submitted by Chain Drug Marketing Association, Inc., covering indications …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-03-23FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for esomeprazole magnesium, a generic proton pump inhibitor.
-
FDA approval · 2020-03-23FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s Esomeprazole Magnesium as a generic version of esomeprazole under an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator [Phase 3]
Phase 3 trial evaluating RHB-105 versus active comparator for Helicobacter pylori infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of a 14-day concomitant therapy for Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy [Phase 4]
A Phase 4 trial evaluating tailored therapy for Helicobacter pylori infection in patients with penicillin allergy has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Effect of Probiotics on Helicobacter Pylori Eradication [Phase 4]
Phase 4 clinical trial evaluating the effect of probiotics on Helicobacter pylori eradication.
-
FDA approval · 2019-11-29FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for Rabeprazole sodium by Advagen Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt [Phase 4]
Phase 4 clinical trial comparing quadruple regimens for Helicobacter pylori infection in Egypt has completed with results posted in 2019.
-
FDA approval · 2019-11-14FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pantoprazole sodium from Torrent Pharmaceuticals Limited.
-
FDA approval · 2019-11-01FDA Approved: TALICIA — Original Application (RedHill Biopharma Ltd)
FDA approved TALICIA, a fixed-dose combination of omeprazole magnesium, amoxicillin, and rifabutin, for Helicobacter pylori infection. The a…
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar [Phase 4]
Phase 4 clinical trial update on the epidemiology and optimal treatment of Helicobacter pylori infection in Myanmar.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: ARJ C13 Urea Breath Test System [Phase 2]
Phase 2 clinical trial of the ARJ C13 Urea Breath Test System for Helicobacter pylori infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp [Phase 4]
A Phase 4 clinical trial evaluating the effect of Helicobacter pylori eradication on the fate of H. pylori-associated gastric polyps has bee…
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: CANHelp Working Group Treatment Trials [Phase 4]
Phase 4 clinical trial update for CANHelp Working Group treatment trials addressing Helicobacter pylori infection has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets [Phase 4]
Phase 4 clinical trial evaluating eradication of Helicobacter pylori using Clostridium butyricum capsules and Bacillus coagulans tablets in …
-
FDA approval · 2019-09-24FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for OMEPRAZOLE AND SODIUM BICARBONATE (omeprazole and sodium bicarbonate) from Oceanside Pharmaceuti…
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients [Phase 4]
A Phase 4 clinical trial comparing high-dose dual therapy to half-dose clarithromycin-containing bismuth quadruple therapy for Helicobacter …
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication. [Phase 4]
Phase 4 trial comparing genotypic resistance-guided therapy to empirical therapy for Helicobacter pylori eradication.
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy [Phase 4]
A Phase 4 trial comparing berberine-amoxicillin quadruple therapy to tetracycline-furazolidone quadruple therapy for Helicobacter pylori-rel…
-
FDA approval · 2019-07-01FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for lansoprazole from Teva Pharmaceuticals USA, Inc. for the generic product under the ANDA process.